Skip to content

CHEMCOM

Active
Public limited companyfounded 200026 yrs activeDrève Richelle 161 P, 1410 Waterloo, BelgiumKBO/BCE: BE 0472.909.840
Summary

CHEMCOM has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€36,451) and a net result of -€75,173. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 272 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability3▼-51
Solvency0▼-27
Growth58▲+26
Track record100
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.79 against 2.25 in 2024; short-term debt: 126.7% and cash: 94.2% of total assets), and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 20
Relative position
BE, all sectors
reference
Manufacture of chemicals and chemical products (NACE 20)
about 43% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-26.7%
Return on assets
-55.1%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 26 years 0 30 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year -€36,451
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
24 d early
2024
333 d late
2023
47 d early
2022
26 d early
2021
58 d early
2020
87 d late
2019
58 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 30 days after the deadline; the sector median for financial year 2024 is 22 days before the deadline, and 27% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 5 July (4 of the last 5 filed years within 32 days of that day).
Companies Code · seven months
Position in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

CHEMCOM was incorporated on 29 September 2000.1 Between 2011 and 2023 the capital was increased 7 times, most recently to EUR 3.2 million.234 The registered office was moved to Waterloo in 2025.5 The board currently has 9 members; Marc PARMENTIER has served longest, since 2006.6 Total assets fell from EUR 4.5 million in 2018 to EUR 136,368 in 2025 and headcount from 13.7 to 1 full-time equivalents.7

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 18-10-2011
  3. 3Belgian State Gazette, 20-05-2022
  4. 4Belgian State Gazette, 03-04-2023
  5. 5Belgian State Gazette, 11-12-2025
  6. 6Belgian State Gazette, 16-09-2024
  7. 7National Bank, annual accounts 2018 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€75,173▲ 59.6%
2024 · -€186,208
Working capital
-€37,040
2024 · €445,557
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 20, Manufacture of chemicals and chemical products, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result-€1.5m▲ 16.8%-€845,026▲ 44.1%-€889,646▼ 5.3%-€168,404▲ 81.1%-€15,540▲ 90.8%
Net result-€1.4mbelow the sector's middle half▲ 18.9%-€739,457below the sector's middle half▲ 45.6%-€886,099below the sector's middle half▼ 19.8%-€186,208below the sector's middle half▲ 79.0%-€75,173below the sector's middle half▲ 59.6%
Equity€1.0mbelow the sector's middle half▼ 59.8%€664,889below the sector's middle half▼ 35.4%€241,692below the sector's middle half▼ 63.6%€38,722below the sector's middle half▼ 84.0%-€36,451below the sector's middle half
Total assets€2.1mbelow the sector's middle half▼ 35.8%€2.5mbelow the sector's middle half▲ 17.5%€2.3mbelow the sector's middle half▼ 9.1%€1.6mbelow the sector's middle half▼ 31.4%€136,368below the sector's middle half▼ 91.3%
Debt€1.1m▲ 46.3%€1.8m▲ 67.1%€2.0m▲ 10.7%€1.5m▼ 25.2%€172,819▼ 88.6%
Working capital-€481,961below the sector's middle half€694,345within the sector's middle half€840,130within the sector's middle half▲ 21.0%€445,557within the sector's middle half▼ 47.0%-€37,040below the sector's middle half
Solvency48.4%within the sector's middle half▼ 29.0pp26.6%below the sector's middle half▼ 21.8pp10.6%below the sector's middle half▼ 16.0pp2.5%below the sector's middle half▼ 8.2pp-26.7%below the sector's middle half▼ 29.2pp
Current ratio0.50below the sector's middle half▼ 2.341.98within the sector's middle half▲ 1.483.90above the sector's middle half▲ 1.912.25within the sector's middle half▼ 1.650.79below the sector's middle half▼ 1.46
Return on assets (ROA)-64.0%below the sector's middle half▼ 13.3pp-29.6%below the sector's middle half▲ 34.4pp-39.0%below the sector's middle half▼ 9.4pp-11.9%below the sector's middle half▲ 27.0pp-55.1%below the sector's middle half▼ 43.2pp
Staff (FTE)10.1below the sector's middle half▼ 19.8%8below the sector's middle half▼ 20.8%7.6below the sector's middle half▼ 5.0%6.3below the sector's middle half▼ 17.1%1below the sector's middle half▼ 84.1%
above within below the middle half (P25 to P75) of NACE 20, Manufacture of chemicals and chemical products, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€2.0m-€1.5m-€1.0m-€500,000€0Operating result 2021: -€1.5m-€1.5mNet result 2021: -€1.4m-€1.4mOperating result 2022: -€845,026-€845,026Net result 2022: -€739,457-€739,457Operating result 2023: -€889,646-€889,646Net result 2023: -€886,099-€886,099Operating result 2024: -€168,404-€168,404Net result 2024: -€186,208-€186,208Operating result 2025: -€15,540-€15,540Net result 2025: -€75,173-€75,17320212022202320242025-€1m-€750,000-€500,000-€250,000€0Operating result 2023: -€889,646-€890,000Net result 2023: -€886,099-€886,000Operating result 2024: -€168,404Net result 2024: -€186,208-€186,000Operating result 2025: -€15,540-€15,500Net result 2025: -€75,173-€75,200202320242025
The operating result stays negative: a loss of €15,540 in 2025 against €168,404 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €136,368
Fixed assets €589 ▼ 99.9%
Current assets €135,779 ▼ 83.1%
Equity and liabilities
Equity-€36,451
Debt€172,819
Equity is negative: debt (€172,819) exceeds the balance-sheet total (€136,368).
Key figures and ratios
2025 value · change against 2024
EBITDA
€27,760▼
2024 · €294,968
Cash flow
-€31,873▼
2024 · €277,165
Interest coverage
0.41▼
2024 · 8.53
Debt ≤ 1 year
€172,819▼
2024 · €357,230
Staff costs
€12,613▼
2024 · €493,341
No debt to equity: equity is negative, so debt divided by equity means nothing.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,621 companies that looked in July 2024 the way this one looks now, 4.5% went bankrupt within 24 months and 84% are still going.

  • Micro
  • 20 years or older
  • negative equity
  • a loss of 10% of the balance sheet or more
4.5% went bankrupt
10.0% stopped otherwise
84% still going

A further 1.0% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.3% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,621 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 48 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.6m€136,368▼
Fixed assets21/28€756,246€589▼
Intangible fixed assets21€742,674-
Tangible fixed assets22/27€12,620-
Plant, machinery and equipment23€12,615-
Furniture and vehicles24€5-
Financial fixed assets28€952€589▼
Current assets29/58€802,787€135,779▼
Amounts receivable within one year40/41€671,480€7,255▼
Trade receivables40€541,795€2,625▼
Other amounts receivable41€129,685€4,630▼
Cash at bank and in hand54/58€126,409€128,524▲
Deferred charges and accrued income490/1€4,898-
Equity and liabilities
Total equity and liabilities10/49€1.6m€136,368▼
Equity10/15€38,722-€36,451▼
Contributions10/11€3.2m€3.2m=
Capital10€3.2m€3.2m=
Issued capital100€3.2m€3.2m=
Reserves13€13,901€13,901=
Non-distributable reserves130/1€13,901€13,901=
Legal reserve130€13,901€13,901=
Profit (loss) carried forward14-€3.2m-€3.2m▼
Amounts payable17/49€1.5m€172,819▼
Amounts payable after more than one year17€1.2m-
Financial debts170/4€1.2m-
Amounts payable within one year42/48€357,230€172,819▼
Trade debts44€299,699€2,180▼
Suppliers440/4€299,699€2,180▼
Taxes, remuneration and social security45€54,037-
Remuneration and social security454/9€54,037-
Other amounts payable47/48€3,494€170,640▲
Accrued charges and deferred income492/3€1,236-
Income statement Code20242025
Remuneration, social security and pensions62€493,341€12,613▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€463,373€43,300▼
Other operating charges640/8€16,574-
Gross operating margin9900€804,883€40,372▼
Operating profit (loss)9901-€168,404-€15,540▲
Financial income75/76B€16,764€8,101▼
Recurring financial income75€16,764€8,101▼
Financial charges65/66B€34,567€67,734▲
Recurring financial charges65€34,567€67,734▲
Profit (loss) for the period before taxes9903-€186,207-€75,173▲
Income taxes67/77€1-
Profit (loss) for the period9904-€186,208-€75,173▲
Profit (loss) for the period to be appropriated9905-€186,208-€75,173▲
Appropriation of the result
Profit (loss) to be appropriated9906-€3.2m-€3.2m▼
Profit (loss) brought forward from the previous period14P-€3.0m-€3.2m▼
Social balance
Average headcount (FTE)90876.31.0▼

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A-€547,645----
Remuneration, social security and pensions62€596,723€574,088€590,215€493,341€12,613▼ 97.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€859,435€464,872€520,034€463,373€43,300▼ 90.7%
Other operating charges640/8€33,659€34,846€31,775€16,574--
Non-recurring operating charges66A-€3,204----
Gross operating margin9900-€20,977€231,984€252,379€804,883€40,372▼ 95.0%
Operating profit (loss)9901-€1.5m-€845,026-€889,646-€168,404-€15,540▲ 90.8%
Financial income75/76B€172,586€152,040€37,717€16,764€8,101▼ 51.7%
Recurring financial income75€172,586€152,040€37,717€16,764€8,101▼ 51.7%
Financial charges65/66B€21,841€46,471€34,170€34,567€67,734▲ 95.9%
Recurring financial charges65€21,841€46,471€34,170€34,567€67,734▲ 95.9%
Profit (loss) for the period before taxes9903-€1.4m-€739,457-€886,099-€186,207-€75,173▲ 59.6%
Income taxes67/77---€1--
Profit (loss) for the period9904-€1.4m-€739,457-€886,099-€186,208-€75,173▲ 59.6%
Profit (loss) for the period to be appropriated9905-€1.4m-€739,457-€886,099-€186,208-€75,173▲ 59.6%
Line20212022202320242025Change
Assets
Total assets20/58€2.1m€2.5m€2.3m€1.6m€136,368▼ 91.3%
Fixed assets21/28€1.6m€1.1m€1.1m€756,246€589▼ 99.9%
Intangible fixed assets21€1.0m€556,312€679,526€742,674--
Tangible fixed assets22/27€630,815€540,761€462,152€12,620--
Land and buildings22€577,164€510,295€443,427---
Plant, machinery and equipment23€49,659€29,273€18,658€12,615--
Furniture and vehicles24€3,993€1,193€67€5--
Financial fixed assets28€952€952€952€952€589▼ 38.1%
Current assets29/58€482,184€1.4m€1.1m€802,787€135,779▼ 83.1%
Amounts receivable after more than one year29-€600,000----
Trade receivables290-€600,000----
Amounts receivable within one year40/41€101,496€391,528€773,542€671,480€7,255▼ 98.9%
Trade receivables40€32,541€372,129€707,577€541,795€2,625▼ 99.5%
Other amounts receivable41€68,955€19,399€65,966€129,685€4,630▼ 96.4%
Cash at bank and in hand54/58€380,688€409,714€356,691€126,409€128,524▲ 1.7%
Deferred charges and accrued income490/1---€4,898--
Equity and liabilities
Total equity and liabilities10/49€2.1m€2.5m€2.3m€1.6m€136,368▼ 91.3%
Equity10/15€1.0m€664,889€241,692€38,722-€36,451▼ 194%
Contributions10/11€5.8m€2.7m€3.2m€3.2m€3.2m=
Capital10€3.8m€2.7m€3.2m€3.2m€3.2m=
Issued capital100€3.8m€2.7m€3.2m€3.2m€3.2m=
Outside capital11€2.0m-----
Share premium1100/10€2.0m-----
Reserves13€13,901€13,901€13,901€13,901€13,901=
Non-distributable reserves130/1€13,901€13,901€13,901€13,901€13,901=
Legal reserve130€13,901€13,901€13,901€13,901€13,901=
Profit (loss) carried forward14-€5.0m-€2.1m-€3.0m-€3.2m-€3.2m▼ 2.4%
Investment grants15€178,070€53,834€16,761---
Amounts payable17/49€1.1m€1.8m€2.0m€1.5m€172,819▼ 88.6%
Amounts payable after more than one year17€133,010€1.1m€1.7m€1.2m--
Financial debts170/4€133,010€1.1m€1.7m€1.2m--
Amounts payable within one year42/48€964,145€706,896€290,104€357,230€172,819▼ 51.6%
Current portion of amounts payable after more than one year42€115,268€122,466€10,544---
Trade debts44€268,931€285,780€209,401€299,699€2,180▼ 99.3%
Suppliers440/4€268,931€285,780€209,401€299,699€2,180▼ 99.3%
Taxes, remuneration and social security45€79,435€294,046€70,159€54,037--
Taxes450/3€12,822€233,147€5,751---
Remuneration and social security454/9€66,613€60,899€64,408€54,037--
Other amounts payable47/48€500,511€4,605-€3,494€170,640▲ 4,784%
Accrued charges and deferred income492/3€743€16,937€41,068€1,236--
Line20212022202320242025Change
Profit (loss) for the period9904-€1.4m-€739,457-€886,099-€186,208-€75,173▲ 59.6%
+ Depreciation and write-downs630€859,435€464,872€520,034€463,373€43,300▼ 90.7%
Operating cash flow (approximation)-€500,614-€274,585-€366,065€277,165-€31,873▼ 111%
Investment in fixed assets (approximation)-€81,396-€564,638-€76,989€712,357▲ 1,025%
Change in cash-€29,025-€53,022-€230,282€2,115▲ 101%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
09-09
State Gazette act Appointments: Joëlle DUMONT (director) and Nathalie Delwart (director)
Permanent representatives: Joëlle DUMONT, Thibaut HOFMAN and Gaëtan WAUCQUEZ7 facts ▸
  • General meeting, 30-06-2026
  • Director appointment, Joëlle DUMONT (director)
  • Permanent representative, Joëlle DUMONT (permanent representative)
  • Director appointment, Nathalie Delwart (director)
  • Director in office, HEXAGON ADVISORY SRL (director)
  • Permanent representative, Thibaut HOFMAN (permanent representative)
  • Permanent representative, Gaëtan WAUCQUEZ (permanent representative)
07-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
29-06
State Gazette act Appointments: Joëlle Dumont (director) and Nathalie Delwart (director)
Permanent representatives: Joëlle Dumont, Gilbert Vassart and Thibaut Hofman7 facts ▸
  • General meeting, 29-05-2026
  • Director appointment, Joëlle Dumont (director)
  • Permanent representative, Joëlle Dumont (permanent representative)
  • Director in office, A.M.I.R. ASBL (director)
  • Permanent representative, Gilbert Vassart (permanent representative)
  • Director appointment, Nathalie Delwart (director)
  • Permanent representative, Thibaut Hofman (permanent representative)
29-06
State Gazette act Resignations: Conthegas Consulting SRL (director) and Charles Delwart (director)
Permanent representatives: Jean-François Pollet and Thibaut Hofman5 facts ▸
  • Board meeting, 04-06-2026
  • Director resignation, Conthegas Consulting SRL (director)
  • Permanent representative, Jean-François Pollet (représentée par)
  • Director resignation, Charles Delwart (director)
  • Permanent representative, Thibaut Hofman (permanent representative)
29-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema · 333 days late
2025
11-12
State Gazette act Registered office · Statutes amendment
Registered-office move3 facts ▸
  • General meeting, 13-08-2025
  • Registered-office move, Drève Richelle 161, 1410 Waterloo
  • Statutes amendment
2024
16-09
State Gazette act Reappointments: COVORIM, CONTHEGAS CONSULTING and 5 others
Permanent representatives: Benedikt Van der Vorst, Jean-François Pollet and 3 others · Resignation: RSM Réviseurs d'Entreprises - Bedrijfsrevisoren SCRL (statutory auditor) · Appointment: EY Bedrijfsrevisoren (statutory auditor)15 facts ▸
  • General meeting, 31-05-2024
  • Director reappointment, COVORIM (director)
  • Permanent representative, Benedikt Van der Vorst
  • Director reappointment, CONTHEGAS CONSULTING (director)
  • Permanent representative, Jean-François Pollet
  • Director reappointment, HEXAGON ADVISORY SRL (director)
  • Permanent representative, Thibaut Hofman
  • Director reappointment, A.M.I.R. (director)
  • Permanent representative, Gilbert Vassart
  • Director reappointment, Gaëtan Waucquez (director)
  • Director reappointment, Marc Parmentier (director)
  • Director reappointment, Charles Delwart (director)
  • +3 further facts in this act
14-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
18-08
State Gazette act Appointment: Gilbert Vassart (director)
Resignation: Jacques Dumont (director) · Permanent representatives: Gilbert Vassart, Thibaut Hofman and Jean-François Pollet8 facts ▸
  • General meeting, 28-06-2023
  • Director appointment, Gilbert Vassart (director)
  • Director resignation, Jacques Dumont
  • Permanent representative, Gilbert Vassart
  • Board composition, Hexagon Advisory SRL (director)
  • Permanent representative, Thibaut Hofman
  • Board composition, Conthegas Consulting SPRL (director)
  • Permanent representative, Jean-François Pollet
05-07
NBB filing Annual accounts filed
fiscal year 2022 · full schema
15-06
State Gazette act Resignation: Jean-Marie Delwart (chair of the board)
Permanent representatives: Thibaut Hofman and Jean-François Pollet6 facts ▸
  • Board meeting, 17-06-2022
  • Director resignation, Jean-Marie Delwart (chair of the board)
  • Board composition, Hexagon Advisory SRL (director)
  • Permanent representative, Thibaut Hofman
  • Board composition, Conthegas Consulting spri (director)
  • Permanent representative, Jean-François Pollet
03-04
State Gazette act Capital & shares
Capital increase · Share issue · Bank account6 facts ▸
  • General meeting, 22-03-2023
  • Capital increase, €499.974,63
  • Share issue, nominatives, 17975
  • Bank account, BNP Paribas Fortis, BE41 0019 4734 3910
  • Capital, €3.196.634,63
  • Statutes amendment
Show earlier events
2022
31-12
Financial Liquidity quadruplescurrent ratio 1.98
Current ratio from 0.50 to 1.98; short-term debt falls from €964,145 to €706,896.
03-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
20-05
State Gazette act Capital & shares
Approval · Capital increase · Capital9 facts ▸
  • General meeting, 29-04-2022
  • Approval, 29-04-2022
  • Capital increase, €500.002,44
  • Capital, €4.328.951,71
  • Bond issue, obligations convertibles, 39547
  • Capital increase, €2.012.364,64
  • Capital decrease, €3.644.656,35
  • Capital, €2.696.660
  • Statutes amendment
07-01
State Gazette act Resignations: Nathalie Delwart (director) and Florinvest SA (director)
Appointments: Charles Delwart, Hexagon Advisory SRL and RSM Réviseurs d'Entreprises · Permanent representatives: Thibaut Hofman and Gert Van Leemput10 facts ▸
  • General meeting, 11-10-2021
  • Director resignation, Nathalie Delwart (director)
  • Director resignation, Florinvest SA (director)
  • Director appointment, Charles Delwart (director)
  • Director appointment, Hexagon Advisory SRL (director)
  • Permanent representative, Thibaut Hofman
  • Auditor appointment, RSM Réviseurs d'Entreprises
  • Permanent representative, Gert Van Leemput
  • Board composition, Gaëtan Waucquez (director)
  • Board composition, Hexagon Advisory SRL (director)
2021
26-10
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 87 days late
05-02
State Gazette act Capital & shares · Statutes amendment
Capital increase · Bank account · Capital4 facts ▸
  • General meeting, 22-12-2020
  • Capital increase, €1.159.996,76
  • Bank account, BNP Paribas Fortis, BE63 0018 9777 6708
  • Capital, €3.828.949,27
2020
31-12
Financial Weakest financial yearnet -€1.7m
Net result drops to -€1.7m, the lowest in the series; recovery starts the following year.
18-08
State Gazette act Capital & shares · Statutes amendment
Capital · Capital increase · Bank account5 facts ▸
  • General meeting, 29-05-2020
  • Statutes amendment
  • Capital, €2.268.972,81
  • Capital increase, €399.979,7
  • Bank account, BNP Paribas Fortis, BE11 0018 8521 9248
30-07
State Gazette act Reappointment: Mazars SC scrl (statutory auditor)
Permanent representative: Christian Van Osselaer3 facts ▸
  • General meeting, 29-05-2020
  • Auditor reappointment, Mazars SC scrl
  • Permanent representative, Christian Van Osselaer
03-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
06-08
State Gazette act Appointments: COVORIM sprl (director) and CONTHEGAS CONSULTING sprl (director)
Permanent representatives: Benedikt Van der Vorst and Jean-François Pollet5 facts ▸
  • General meeting, 03-06-2019
  • Director appointment, COVORIM sprl (director)
  • Permanent representative, Benedikt Van der Vorst
  • Director appointment, CONTHEGAS CONSULTING sprl (director)
  • Permanent representative, Jean-François Pollet
13-06
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
17-09
State Gazette act Capital & shares
Capital increase · Bank account · Net-asset statement6 facts ▸
  • Capital increase, €1.600.141,32
  • Bank account, BNP PARIBAS FORTIS, BE27 0018 4414 2273
  • Capital increase, €581.110,98
  • Net-asset statement, 30-06-2018
  • Capital, €2.268.972,81
  • Statutes amendment
31-07
State Gazette act Reappointments: Biotec SA, Florinvest SA and 4 others
Permanent representatives: Jean-Marie Delwart and Christian Van Osselaer · Intermediary10 facts ▸
  • General meeting, 25-05-2018
  • Director reappointment, Biotec SA (director)
  • Director reappointment, Florinvest SA (director)
  • Director reappointment, Gaëtan Waucquez (director)
  • Director reappointment, Nathalie Delwart (director)
  • Director reappointment, Marc Parmentier (director)
  • Director reappointment, Jacques Dumont (director)
  • Permanent representative, Jean-Marie Delwart
  • Permanent representative, Christian Van Osselaer
  • Intermediary, Florinvest SA
31-05
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
01-08
State Gazette act Reappointment: Mazars (statutory auditor)
Permanent representative: BIOTRAC spri3 facts ▸
  • General meeting, 29-06-2017
  • Auditor reappointment, Mazars
  • Permanent representative, BIOTRAC spri
11-07
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2016
21-01
State Gazette act Capital & shares · Statutes amendment
Capital decrease · Capital · Power of attorney5 facts ▸
  • General meeting, 17-12-2015
  • Capital decrease, €4.400.000
  • Capital, €87.720,51
  • Statutes amendment
  • Power of attorney, Conseil d'administration
2015
08-01
State Gazette act Capital & shares
Capital increase · Capital · Power of attorney4 facts ▸
  • General meeting, 03-12-2014
  • Capital increase, €1.000.060,51
  • Capital, €4.487.720,51
  • Power of attorney, Conseil d'administration
2014
01-07
State Gazette act Reappointment: Mazars (statutory auditor)
Permanent representative: Christian Van Osselaer3 facts ▸
  • General meeting, 30-05-2014
  • Auditor reappointment, Mazars
  • Permanent representative, Christian Van Osselaer
2012
06-09
State Gazette act Resignation: COMPAGNIE DU BOIS SAUVAGE SA (director)
Reappointments: Biotec SA, Florinvest SA and 4 others · Permanent representative: Christian Van Osselaer9 facts ▸
  • General meeting, 22-08-2012
  • Director resignation, COMPAGNIE DU BOIS SAUVAGE SA (director)
  • Director reappointment, Biotec SA (director)
  • Director reappointment, Florinvest SA (director)
  • Director reappointment, Gaëtan Waucquez (director)
  • Director reappointment, Nathalie Delwart (director)
  • Director reappointment, Marc Parmentier (director)
  • Director reappointment, Jacques Dumont (director)
  • Permanent representative, Christian Van Osselaer
2011
18-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Power of attorney6 facts ▸
  • General meeting, 23-09-2011
  • Statutes amendment
  • Statutes amendment
  • Statutes amendment
  • Capital increase, €179.760
  • Power of attorney, Conseil d'administration de CHEMCOM
03-08
State Gazette act Reappointments: Jacques Dumont (director) and Gaëtan Waucquez (director)
Appointments: Compagnie du Bois Sauvage, Nathalie Delwart and Mazars · Permanent representatives: Laurent Puissant Bayens and Philippe Gossart · Resignation: Charles Delwart (director)11 facts ▸
  • General meeting, 27-05-2011
  • Director reappointment, Jacques Dumont (director)
  • Director reappointment, Gaëtan Waucquez (director)
  • Director appointment, Compagnie du Bois Sauvage (director)
  • Permanent representative, Laurent Puissant Bayens
  • Director appointment, Nathalie Delwart (director)
  • Director resignation, Charles Delwart (director)
  • Auditor appointment, Mazars (statutory auditor)
  • Mandate compensation, Mazars
  • Permanent representative, Philippe Gossart
  • Board decision ratification, Conseil d'Administration du 15 octobre 2010 et du 11 mai 2011
2010
28-07
State Gazette act Resignation: Alexandre Schmitz (director)
Permanent representatives: Christian VAN OSSELAER and Gaëtan WAUCQUEZ4 facts ▸
  • General meeting, 28-05-2010
  • Director resignation, Alexandre Schmitz (director)
  • Permanent representative, Christian VAN OSSELAER
  • Permanent representative, Gaëtan WAUCQUEZ
2008
15-07
State Gazette act Appointments: SCPRL Chartes de Streel (statutory auditor) and Laurent Puissant Baeyens (représentant de metrobel s.a.)
Resignation: Guy Paquot (représentant de metrobel s.a.) · Reappointment: EUROSCREEN (director) · Permanent representatives: Jean-Marie DELWART and Christian VAN OSSELAER7 facts ▸
  • General meeting, 30-05-2008
  • Auditor appointment, SCPRL Chartes de Streel (statutory auditor)
  • Director appointment, Laurent Puissant Baeyens (représentant de metrobel s.a.)
  • Director resignation, Guy Paquot (représentant de metrobel s.a.)
  • Director reappointment, EUROSCREEN (director)
  • Permanent representative, Jean-Marie DELWART
  • Permanent representative, Christian VAN OSSELAER
2007
31-05
State Gazette act Capital & shares · Miscellaneous
Demerger · Power of attorney4 facts ▸
  • Demerger, Apport par la société Chemcom de sa branche d'activité « olfaction humaine » à la société Tecnoscent Flonnvest SA
  • Power of attorney, Biotrac SPRL
  • Power of attorney, Christian Van Osselaer
  • Power of attorney, Jean-Marie Delwart
2006
08-09
State Gazette act Reappointments: BIOTEC, FLORINVEST and Marc Parmentier
Permanent representatives: Jean-Marie Delwart, BIOTRAC SPRL and Christian Van Osselaer7 facts ▸
  • General meeting, 26-05-2006
  • Director reappointment, BIOTEC (director)
  • Permanent representative, Jean-Marie Delwart
  • Director reappointment, FLORINVEST (director)
  • Permanent representative, BIOTRAC SPRL
  • Permanent representative, Christian Van Osselaer
  • Director reappointment, Marc Parmentier (director)
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
27 of 27 acts read

Directors · office · real estate

Directors
9 directors, no change since 2026

Board 9

Marc PARMENTIER
Director · since 26-05-2006
Current
Gäetan Waucquez
Director · since 28-05-2010
Current
HEXAGON ADVISORY SRL
Director · since 11-10-2021 · Legal entity · perm. rep.: Thibaut Hofman
Current
Gilbert Vassart
Director · since 28-06-2023
Current
A.M.I.R.
Director · since 31-05-2024 · Legal entity · perm. rep.: Gilbert Vassart
Current
CONTHEGAS CONSULTING
Director · since 31-05-2024 · Legal entity · perm. rep.: Jean-François Pollet
Current
COVORIM
Director · since 31-05-2024 · Legal entity · perm. rep.: Benedikt Van der Vorst
Current
Joëlle Dumont
Director · since 29-06-2026
Current
Show all 9 directors
Nathalie Delwart
Director · since 29-06-2026
Current
6 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Biotec
Director · since 26-05-2006 · Legal entity · perm. rep.: Jean-Marie Delwart
Not recently confirmed
FLORINVEST
Director · since 26-05-2006 · Legal entity
Not recently confirmed
EUROSCREEN
Director · since 30-05-2008 · Legal entity
Not recently confirmed
Compagnie Du Bois Sauvage
Director · since 27-05-2011 · Legal entity · perm. rep.: Laurent Puissant Bayens
Not recently confirmed
Biotec sa
Director · since 25-05-2018 · Legal entity · perm. rep.: Jean-Marie Delwart
Not recently confirmed
COVORIM
Director · since 03-06-2019 · Private limited company · perm. rep.: Benedikt Van der Vorst
Not recently confirmed

Permanent representatives 4

Thibaut Hofman
Permanent representative · since 11-10-2021 · for HEXAGON ADVISORY SRL
Current
Benedikt Van der Vorst
Permanent representative · since 31-05-2024 · for COVORIM
Current
Gilbert Vassart
Permanent representative · since 31-05-2024 · for A.M.I.R.
Current
Jean-François Pollet
Permanent representative · since 31-05-2024 · for CONTHEGAS CONSULTING
Current
3 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Laurent Puissant Baeyens
Représentant de metrobel s.a. · since 30-05-2008
Not recently confirmed
Laurent Puissant Bayens
Permanent representative · since 27-05-2011 · for Compagnie Du Bois Sauvage
Not recently confirmed
Jean-Marie Delwart
Permanent representative · since 25-05-2018 · for Biotec sa
Not recently confirmed

Statutory auditor 1

Ernst et Young Reviseurs d'Entreprises
Statutory auditor · since 31-05-2024 · perm. rep.: Carlo-Sébastien D'Addario
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Waterloo · 1 establishment unit since 2001
seat establishment The establishment unit on the map
Ground area
1.2 ha
Building footprint
2,260 m²
Volume, LiDAR
37,294 m³
2 parcels, Brussels, Wallonia · tallest building 22.9 m, ±6 floors. Linked by address, not a title deed.
10 companies at this address See who is registered here
1 establishment unit
CHEMCOM
Lennikse Baan 802, 1070 AnderlechtScientific research and development
since 20012.098.181.165
2 parcels
Wallonia 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
25763M0621/00F000indicative Wallonia 1.0 ha 1 · 1,772 m² 22.9 m · 6 fl.
21307E0036/00B003 Brussels 1,843 m² 1 · 487 m² 20.9 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

28 people since 2006, 17 in office
Show
  • Board
  • Permanent representative
  • Statutory auditor
  • not recently confirmed
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Marc PARMENTIER
  • Director, already before 26-05-2006 to date
Gäetan Waucquez
  • Director, already before 28-05-2010 to date
Nathalie Delwart
  • Director, from 27-05-2011 to 11-10-2021
  • Director, from 29-06-2026 to date
HEXAGON ADVISORY SRL
  • Director, from 11-10-2021 to date
Gilbert Vassart
  • Director, from 28-06-2023 to date
A.M.I.R.
  • Director, already before 31-05-2024 to date
CONTHEGAS CONSULTING
  • Director, already before 31-05-2024 to date
COVORIM
  • Director, already before 31-05-2024 to date
Joëlle Dumont
  • Director, from 29-06-2026 to date
Ernst et Young Reviseurs d'Entreprises
  • Statutory auditor, from 31-05-2024 to date
Biotec
  • Director, already before 26-05-2006 not ended, last confirmed 08-09-2006
FLORINVEST
  • Director, already before 26-05-2006 not ended, last confirmed 08-09-2006
EUROSCREEN
  • Director, already before 30-05-2008 not ended, last confirmed 15-07-2008
Compagnie Du Bois Sauvage
  • Director, from 27-05-2011 not ended, last confirmed 03-08-2011
Biotec sa
  • Director, already before 06-09-2012 not ended, last confirmed 31-07-2018
COVORIM
  • Director, from 03-06-2019 not ended, last confirmed 06-08-2019
Laurent Puissant Baeyens
  • Représentant de metrobel s.a., from 30-05-2008 not ended, last confirmed 15-07-2008
Charles Delwart
  • Director, until 27-05-2011
  • Director, from 11-10-2021 to 29-05-2026
CONTHEGAS CONSULTING
  • Director, from 03-06-2019 to 28-02-2025
RSM Reviseurs d'Entreprises-Bedrijfsrevisoren
  • Auditor, from 11-10-2021 to 31-05-2024
Jacques Dumont
  • Director, already before 28-05-2010 to 28-06-2023
Jean-Marie Delwart
  • Chair of the board, until 07-07-2022
Florinvest SA
  • Director, already before 06-09-2012 to 11-10-2021
Mazars SC scrl
  • Auditor, from 27-05-2011 to 11-10-2021
COMPAGNIE DU BOIS SAUVAGE SA
  • Director, until 22-08-2012
SCPRL Chartes de Streel
  • Statutory auditor, from 30-05-2008 to 27-05-2011
Alexandre Schmitz
  • Director, until 28-05-2010
Guy Paquot
  • Représentant de metrobel s.a., until 30-05-2008
See the board, name and seat on a given date →

Articles of association

Purpose
La recherche, la mise au point et le développement de produits nouveaux et de procédés novateurs issus du développement des techniques de biologie et de génétique moléculaires dans…
Full purpose

La recherche, la mise au point et le développement de produits nouveaux et de procédés novateurs issus du développement des techniques de biologie et de génétique moléculaires dans le domaine médical, pharmaceutique, biologique, chimique, agro alimentaire, et particulièrement la communication chimique et les récepteurs olfactifs; la fabrication, la transformation, l'achat, la vente, la représentation, la location, l'importation ou l'exportation de tous produits, machines, matériaux, conditionnements et matières ou la fourniture de tout service en rapport avec la recherche, l'exploitation et la commercialisation de ces produits et procédés.

Structure & network

Owners and holdings

4 owners · 1 holding

Owners 4

Holdings 1

According to the 2025 annual accounts of CHEMCOM and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

13 connected companies
Linked via shared directors
AGEMAR
via Gäetan Waucquez · Director
→
Floridienne
via Gäetan Waucquez · Managing director
→
→
Show 9 more companies with a shared director

Acquisitions and mergers

1 transaction
Split off to:Tecnoscent Flonnvest SA
proposal · State Gazette act of 31-05-2007

Capital and shareholders

Capital over the years
  1. 03-04-2023 Capital increase of 499,974.63 EUR · to 3,196,634.63 EUR · 17,975 new shares
  2. 20-05-2022 Capital increase of 500,002.44 EUR · to 4,328,951.71 EUR · 8,988 new shares · “apport de diverses créances – avances d'actionnaires”
  3. 20-05-2022 Capital increase of 2,012,364.64 EUR · to 6,341,316.35 EUR · no new shares · from reserves
  4. 20-05-2022 Capital reduction of 3,644,656.35 EUR · to 2,696,660 EUR · to absorb losses
  5. 05-02-2021 Capital increase of 1,159,996.76 EUR · to 3,828,949.27 EUR · 20,852 new shares
  6. 18-08-2020 Capital increase of 399,979.70 EUR · to 2,668,952.51 EUR · 7,190 new shares
  7. 17-09-2018 Capital increase of 1,600,141.32 EUR · to 1,687,861.83 EUR · 28,764 new shares · in cash
  8. 17-09-2018 Capital increase of 581,110.98 EUR · to 2,268,972.81 EUR · 10,446 new shares · in kind
Show 3 older capital entries
  1. 21-01-2016 Capital reduction of 4,400,000 EUR · to 87,720.51 EUR · to absorb losses
  2. 08-01-2015 Capital increase of 1,000,060.51 EUR · to 4,487,720.51 EUR · 17,977 new shares
  3. 18-10-2011 Capital increase of 179,760 EUR · to 3,487,660 EUR · 8,988 new shares

Similar companies · same sector, comparable size

Of 243 companies in this sector we hold annual accounts for 96. 25 are within a factor 10 of this headcount. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPublic limited company
Founded29-09-2000
Fiscal year end31-12
Activities, NACEBEL 2025
20420Manufacture of chemicals and chemical products
46120Wholesale trade
E-invoicing
Reachable via Peppol
Peppol ID 0208:0472909840
Registered 22-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.